BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34426433)

  • 1. Atypical fibroxanthoma of hand.
    Kampalli G; Tripathy S; Nair S; Sharma RK
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34426433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Fibroxanthoma.
    Chapman LW; Yu SS; Arron ST
    Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiated Skeletal Muscle Cells Mimicking Those of Atypical Fibroxanthoma on Mohs Frozen Sections.
    Xiong MY; Kolker S; Bennett RG
    Am J Dermatopathol; 2021 May; 43(5):362-364. PubMed ID: 32956095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
    Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
    J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
    Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
    J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical fibroxanthoma/malignant fibrous histiocytoma.
    Marcet S
    Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid Carcinoma With Quasi-Complete Loss of Cytokeratin Expression or Keratin-Positive Atypical Fibroxanthoma.
    Roy SF; Lafaille P; Désy D
    Int J Surg Pathol; 2019 Aug; 27(5):518-520. PubMed ID: 30760056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of pleomorphic dermal sarcoma with perineural invasion treated with Mohs micrographic surgery and adjuvant radiation therapy.
    Kurtti A; Farhadian J; Meehan S; Madu P; Bradu S
    Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: A probability model based on a systematic review.
    Jibbe A; Worley B; Miller CH; Alam M
    J Am Acad Dermatol; 2022 Oct; 87(4):833-840. PubMed ID: 34587553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
    Soleymani T; Aasi SZ; Novoa R; Hollmig ST
    Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic atypical fibroxanthoma.
    Satter EK
    Dermatol Online J; 2012 Sep; 18(9):3. PubMed ID: 23031370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized cutaneous metastases from an atypical fibroxanthoma.
    Giuffrida TJ; Kligora CJ; Goldstein GD
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical fibroxanthoma: new insights.
    Hussein MR
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to recurrence after surgical excision of atypical fibroxanthoma-updated systematic review and meta-analysis.
    Phan K; Onggo J
    Australas J Dermatol; 2019 Aug; 60(3):e220-e222. PubMed ID: 30793288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse Dorsal Metacarpal Artery Flaps to Repair Distal Hand and Dorsal Finger Defects After Mohs Micrographic Surgery.
    Aizman L; Perz AM; Lukowiak TM; Sobanko JF; Miller CJ; Etzkorn JR
    Dermatol Surg; 2021 Aug; 47(8):1130-1132. PubMed ID: 33941730
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review.
    Rosenfeld DJ; Cappel MA; Tolkachjov SN
    Int J Dermatol; 2021 Nov; 60(11):1334-1342. PubMed ID: 33715156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.